iifl-logo

Vivanza Biosciences Ltd Share Price

2.08
(-2.80%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open2.14
  • Day's High2.14
  • 52 Wk High7.65
  • Prev. Close2.14
  • Day's Low2.04
  • 52 Wk Low 1.9
  • Turnover (lac)1.92
  • P/E0
  • Face Value1
  • Book Value1.23
  • EPS0
  • Mkt. Cap (Cr.)8.32
  • Div. Yield0
View All Historical Data
No Records Found

Vivanza Biosciences Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

2.14

Prev. Close

2.14

Turnover(Lac.)

1.92

Day's High

2.14

Day's Low

2.04

52 Week's High

7.65

52 Week's Low

1.9

Book Value

1.23

Face Value

1

Mkt Cap (₹ Cr.)

8.32

P/E

0

EPS

0

Divi. Yield

0

Vivanza Biosciences Ltd Corporate Action

5 Jul 2024

12:00 AM

BookCloser

arrow

5 Jul 2024

12:00 AM

AGM

Announcement Date: 05 Jul, 2024

arrow

20 Mar 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Vivanza Biosciences Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Vivanza Biosciences Ltd SHAREHOLDING SNAPSHOT

09 May, 2025|05:47 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 20.01%

Foreign: 0.00%

Indian: 20.01%

Non-Promoter- 0.01%

Institutions: 0.00%

Non-Institutions: 79.97%

Custodian: 0.00%

Share Price

Vivanza Biosciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

4

4

4

4

Preference Capital

0

0

0

0

Reserves

0.72

0.4

-0.17

-0.63

Net Worth

4.72

4.4

3.83

3.37

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

9.14

9.22

9.42

6.44

yoy growth (%)

-0.82

-2.18

46.4

85.35

Raw materials

-8.48

-8.56

-9.13

-5.52

As % of sales

92.71

92.83

96.88

85.85

Employee costs

-0.11

-0.29

-0.25

-0.1

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

0.46

0.14

-0.2

0.26

Depreciation

0

0

0

0

Tax paid

0

-0.04

0

-0.02

Working capital

4.72

0.09

-1.25

0.48

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-0.82

-2.18

46.4

85.35

Op profit growth

-61.07

-141.68

-147.48

-495.32

EBIT growth

41.27

166.09

-63.7

-651.11

Net profit growth

364.35

-149

-184.9

-251.1

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

27.84

17.81

10.4

9.89

9.62

Excise Duty

0

0

0

0

0

Net Sales

27.84

17.81

10.4

9.89

9.62

Other Operating Income

0

0

0

0

0

Other Income

0.05

0.48

0.83

0.51

0.57

Vivanza Biosciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,766.2

134.524,23,770.541,181.050.765,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,958.35

76.31,58,175.475940.52,297513.62

Cipla Ltd

CIPLA

1,486.75

25.81,20,075.941,438.150.874,134.87360.72

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,183

59.051,07,722.354850.882,330222.38

Mankind Pharma Ltd

MANKIND

2,434.1

51.931,00,425.74416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Vivanza Biosciences Ltd

Management

Register Office

Registrar Office

Non Executive Director

Hemant Parikh

Managing Director

Jayendra Mehta

Independent Director

Rina Kumari

Independent Director

Shah A P

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Vivanza Biosciences Ltd (Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992. Head quartered in Gujarat, India, the Company came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.The Company is presently engaged in the business of Pharmaceutical Products and Pharma Products.However Competition in the industry is continuously increasing. New technology is being adopted and steps are taken to improve the manufacturing capacity of the Company. Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units.The company undertook an expansion-cum-diversification programme to increase its capacity from 18 lac pa to 54 lac pa. It also proposed to diversify into the manufacture of small volume parenterals with an installed capacity of 294 lac pa. It came out with a public issue of 21,70,000 equity shares of Rs 10 each for cash at par aggregating Rs 217 lac. It is one of the few companies which has facilities for both glass as well as plastic containers. Due to recessionary trends which lead to difficult business conditions in the year 1999-2000, the parenteral industry suffered a setback. As a result of this, the name of the Company was changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd in 2015.The Company
Read More

Company FAQs

What is the Vivanza Biosciences Ltd share price today?

The Vivanza Biosciences Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹2.08 today.

What is the Market Cap of Vivanza Biosciences Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vivanza Biosciences Ltd is ₹8.32 Cr. as of 09 May ‘25

What is the PE and PB ratio of Vivanza Biosciences Ltd?

The PE and PB ratios of Vivanza Biosciences Ltd is 0 and 1.73 as of 09 May ‘25

What is the 52 Week High and Low of Vivanza Biosciences Ltd?

The 52-week high/low is the highest and lowest price at which a Vivanza Biosciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vivanza Biosciences Ltd is ₹1.9 and ₹7.65 as of 09 May ‘25

What is the CAGR of Vivanza Biosciences Ltd?

Vivanza Biosciences Ltd's CAGR for 5 Years at 11.35%, 3 Years at -51.62%, 1 Year at -69.08%, 6 Month at -50.12%, 3 Month at -1.83% and 1 Month at -4.04%.

What is the shareholding pattern of Vivanza Biosciences Ltd?

The shareholding pattern of Vivanza Biosciences Ltd is as follows:
Promoters - 20.02 %
Institutions - 0.00 %
Public - 79.98 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.